We investigated cell death during glucose deprivation in rat cardiomyocyte-derived H9c2 cells. Electron microscopic analysis revealed accumulation of autophagic vacuoles during glucose deprivation. The addition of 3-methyladenine or LY294002, which are known to inhibit autophagosome formation, reduced cell death while Z-VAD-FMK, a caspase inhibitor, slightly affected cell death. Thus, cell death during glucose deprivation is not type I programmed cell death (apoptotic cell death) but type II programmed cell death (autophagic cell death). Moreover, we found that both insulin-like growth factor-I and the adenovirus-mediated overexpression of wild-type class I PI 3-kinase accelerated cell death as well as accumulation of autophagic vacuoles during glucose deprivation while dominant-negative PI 3-kinase reduced these phenomena. The results indicate that IGF-I/PI 3-kinase accelerates the accumulation of autophagic vacuoles and subsequent autophagic cell death during glucose deprivation, revealing the opposing role of IGF-I/ PI 3-kinase in two distinct types of programmed cell death (apoptotic and autophagic cell death).
We investigated cell death during glucose deprivation in rat cardiomyocyte-derived H9c2 cells. Electron microscopic analysis revealed accumulation of autophagic vacuoles during glucose deprivation. The addition of 3-methyladenine or LY294002, which are known to inhibit autophagosome formation, reduced cell death while Z-VAD-FMK, a caspase inhibitor, slightly affected cell death. Thus, cell death during glucose deprivation is not type I programmed cell death (apoptotic cell death) but type II programmed cell death (autophagic cell death). Moreover, we found that both insulin-like growth factor-I and the adenovirus-mediated overexpression of wild-type class I PI 3-kinase accelerated cell death as well as accumulation of autophagic vacuoles during glucose deprivation while dominant-negative PI 3-kinase reduced these phenomena. The results indicate that IGF-I/PI 3-kinase accelerates the accumulation of autophagic vacuoles and subsequent autophagic cell death during glucose deprivation, revealing the opposing role of IGF-I/ PI 3-kinase in two distinct types of programmed cell death (apoptotic and autophagic cell death). Oncogene (2003 Oncogene ( ) 22, 8529-8535. doi:10.1038 Keywords: phosphoinositide 3-kinase; autophagy; glucose deprivation; cell death Autophagy is a bulk protein degradation system that is essential for normal cell activities as well as for cell survival under nutrient-deficient conditions (Seglen and Bohley, 1992; Blommaart et al., 1997) . The initial step in autophagy is the formation of a double-membrane structure, the so-called autophagosome, which includes in its structure cytoplasmic contents as well as organelles. Autophagosomes finally fuse with lysosomes, their contents are degraded by lysosomal hydrolytic proteases. Although recent advances have revealed some of the molecular mechanisms underlying autophagy (Klionsky and Ohsumi, 1999; Ohsumi, 2001) , its role in cell death is poorly understood. Autophagic cell death, which can be categorized into type II programmed cell death as opposed to type I programmed cell death (apoptotic cell death), is characterized by the appearance of large autophagic vacuoles in the cytoplasm and is observed during embryogenesis (Schweichel and Merker, 1973; Clarke, 1990) . The involvement of autophagy in human neurodegenerative disease is observed in Alzheimer's diseases (Nixon et al., 2000) as well as Parkinson's diseases (Anglade et al., 1997) , and is also observed in degenerating mouse neurons expressing mutant huntingtin (Kegal et al., 2000) .
Phosphoinositide 3-kinase (PI 3-kinase) is a family of lipid kinases that catalyses the phosphorylation of phosphoinositides [PI, PI(4)P, and PI(4, 5)P 2 ] at the D-3 position (Rameh and Cantley, 1999) . While class I PI 3-kinase serve PI(4)P and PI(4, 5)P 2 as substrates, class III PI 3-kinase serve PI as substrate. It has been reported that class I PI 3-kinases inhibit while the class III PI 3-kinase stimulate autophagic protein degradation in HT-29 human colon cancer cells (Petiot et al., 2000; Arico et al., 2001) . These studies report that class I PI 3-kinase products [PI(3,4)P 2 and PI(3,4,5)P 3 ] inhibit while class III PI 3-kinase products [PI(3)P] stimulate autophagic protein degradation. Class I PI 3-kinase is shown to mediate various cellular functions including metabolic actions of insulin, such as glucose transport and glycogen synthesis, and the suppression of apoptosis while class III PI 3-kinase is involved in membrane traffic. Although class I PI 3-kinase is a crucial mediator of the antiapoptotic effect of insulin-like growth factor-I in hypoxic cardiomyocytes (Matsui et al., 1999) , we have shown that class I PI 3-kinase accelerates necrosis of the rat cardiomyocyte-derived cell line H9c2 during hypoxia (Aki et al., 2001) , raising the possibility that class I PI 3-kinase accelerates cell death in a manner distinct from apoptosis. This prompted us to examine the effect of class I PI 3-kinase on physiological cell deaths other than apoptotic cell death.
The incubation of H9c2 rat cardiomyocyte-derived cells in glucose-free medium for 24 h resulted in slight cell death compared to control cells, and further incubation for 48 h resulted in death in about 70% of cells ( Figure 1a ). Addition of IGF-I, which is known to inhibit apoptosis, accelerates cell death during glucose deprivation slightly but significantly (Figure 1a ), suggesting that H9c2 cell death during glucose deprivation may not be apoptosis. Analysis of the morphology of dead cells by transmission electron microscopy revealed the cytoplasmic accumulation of autophagic vacuoles as well as nuclear chromatin condensation (Figure 1b ), characteristic features of autophagic and apoptotic cell death, respectively (Schweichel and Merker, 1973; Zakeri et al., 1995; Fiers et al., 1999; Kitanaka and Kuchino, 1999; Bursch, 2001) .
To evaluate whether the cell death during glucose deprivation is autophagic or apoptotic, we examined the effect of inhibitors. H9c2 cell death during glucose deprivation is markedly reduced by 3-methyladenine or LY294002 (Figure 2a) , both of which are reported to inhibit the formation of autophagosomes by inhibiting PI 3-kinase (Seglen and Gordon, 1982; Blommaart et al., 1997) . In contrast, the caspase inhibitor Z-VAD-FMK had only a slight effect on cell death (Figure 2a) , indicating that the caspase-dependent apoptotic machinery is scarcely involved in cell death during glucose deprivation. We also observed that 3MA reduced viability of the cells during amino-acids deprivation, suggesting that autophagy might be involved in cell survival during amino-acids deprivation (data not shown). LY294002 also inhibited C2C12 mouse myoblast cell death while it had no effect on death of PC12 rat carcinoma cells and HepG2 human hepatoma cells during glucose deprivation (Figure 2b ), as reported by Izuishi et al. (2000) . Therefore, acceleration of cell death by PI 3-kinase during glucose deprivation is not a general phenomenon among cell lines derived from various tissues. However, this phenomenon might be general to some extent among myocyte-derived cells because both H9c2 and C2C12 cells are derived from myocyte. Since LY294002 is an inhibitor for both class I and class III PI 3-kinase, we next examined the effects of overexpression of wild-type or dominant-negative class I PI 3-kinases to clarify the involvement of class I PI 3-kinase. As shown in Figure 2c , wild-type PI 3-kinase as well as IGF-I accelerated cell death during glucose deprivation while dominant-negative PI 3-kinase reduced cell death ( Figure 2c ). Effective use of adenovirusmediated gene transfer and the activation or inactivation of its downstream target protein Akt were confirmed by Western blotting (Figure 2d) . Figure 1 Accumulation of autophagosomes during glucose deprivation-induced cell death. (a) H9c2 rat cardiomyocyte-derived cells were grown to confluence on 35 mm diameter dishes in DMEM (4.5 g/l glucose) supplemented with 10% fetal bovine serum, then preconditioned in serum-free DMEM for 48 h. Glucose deprivation (Àglucose) was achieved by changing the glucosecontaining, serum-free DMEM to serum and glucose free-DMEM. Control experiments were performed by changing the medium to fresh glucose-containing serum-free DMEM ( þ glucose). Insulinlike growth factor-I (IGF-I; Austral Biologicals, San Ramon, CA, USA) was added at a final concentration of 100 ng/ml during glucose deprivation (Àglucose þ IGF-I). Viability of the cells was measured by dye-exclusion assay. In brief, trypsinized cells were mixed 1 : 1 with 0.2% trypan blue and viable cell numbers relative to control was determined. The data represent typical results performed in triplicate for at least three times (means and s.d., n ¼ 3). (b) Ultrastructural analysis of cell death during glucose deprivation under transmission electron microscopy. Cells were incubated in glucose-containing ( þ glucose) or glucose-free (Àglucose) DMEM for 48 h. Electron microscopy was performed as described (Aki et al., 2001) . Autophagosomes are indicated with arrows PI 3-kinase accelerates autophagic cell death T Aki et al
We next examined the effect of inhibitors and gene transfers on the accumulation of autophagic vacuoles. Light microscopic observations revealed both the accumulation of large vacuoles in the cytoplasm and cell death during 48 h of glucose deprivation, while these were reduced by either 3MA, LY294002 (Figure 3a) . Z-VAD-FMK had no effect on both vacuole formation and cell death (Figure 3a) . Cell death during 48 h of glucose deprivation was accelerated by wild-type PI 3-kinase while both vacuole formation and cell death were reduced by dominant-negative PI 3-kinase (Figure 3a) . The formation of vacuoles during 30 h of glucose deprivation was accelerated by both IGF-I-and wildtype PI 3-kinase while effect of IGF-I was reduced by dominant-negative PI 3-kinase (Figure 3b ). Staining cells with monodancylcadaverine (MDC), a fluorescence dye incorporated selectively into autophagosomes (Biederbick et al., 1995; Munafo˜and Colombo, 2001) revealed that cells treated with IGF-I or that overexpress wild-type PI 3-kinase accumulate numerous autophagosomes in the cytoplasm even after 24 h of glucose deprivation and effect of IGF-I was reduced by dominant-negative PI 3-kinase (Figure 3c ). Electron microscopic analysis also revealed that after 30 h of glucose deprivation, numerous autophagosomes were accumulated in the cytoplasm (Figure 3d ). In contrast, when IGF-I was added, numerous vacuoles were accumulated (Figure 3d) . Thus, IGF-I might accelerate conversion of autophagosomes into autophagic vacuoles during glucose deprivation. Taken together, IGF-I/PI 3-kinase accelerates the formation/accumulation of autophagic vacuoles during glucose deprivation.
To evaluate further the effects of inhibitors or gene transfers on the formation of autophagosomes, we examined the formation of LC3-II, a processed form of LC3, during glucose deprivation. The formation of LC3-II was shown to correlate well with the contents of autophagosome membranes, making it a good marker for autophagosomes (Kabeya et al., 2000) . Glucose deprivation markedly induced LC3-II formation, which Figure 2 Effect of inhibitors and the overexpression of wild-type or dominant-negative PI 3-kinases on cell death during glucose deprivation. Viability of the cells during the indicated times of glucose deprivation is shown (means and s.d., n ¼ 3). (a) H9c2 cell death during glucose deprivation was reduced by inhibitors of autophagosome formation, but not by a caspase inhibitor. 3-Methyladenine (3MA; ICN Biomedicals Inc. Aurora, OH, USA), Z-VAD-FMK (Promega, Co., Madison, WI, USA) and LY294002 (Calbiochem Co., San Diego, CA, USA) were added at final concentrations of 10 mM, 50 mM and 10 mM, respectively. (b) LY294002 also inhibits C2C12 cell death but not PC12 and HepG2 cell deaths during glucose deprivation. (c) IGF-I and wild-type PI 3-kinase accelerates H9c2 cell death during glucose deprivation. IGF-I was added at a final concentration of 100 ng/ml during glucose deprivation. The catalytic subunit (p110) of PI 3-kinase (PI 3-K-WT) and a deletion mutant of the regulatory subunit of PI 3-kinase (Dp85, PI 3-K-DN), which lacks the p110 binding region, were expressed by adenoviruses (Katagiri et al., 1996 (Katagiri et al., , 1997 . The cells were infected with the viruses at a multiplicity of infection of 20-30 plaque-forming units/cell one day before being subjected to glucose deprivation. (d) Effect of adenovirus-mediated gene transfer. Western blot analyses were performed as described (Aki et al., 2001) . Equal amounts of cell extract were subjected to electrophoresis in 10% gels, blotted onto nitrocellulose membranes, and probed with anti-p110a (Transduction Laboratories, Lexington, KY, USA), -p85a (Transduction Laboratories), -Akt (New England Biolabs, Beverly, MA, USA), or phospho-Akt (Ser-473, New England Biolabs) antibodies (Figure 4a ). Moreover, wildtype PI 3-kinase accelerated the formation of LC3-II, while dominant-negative PI 3-kinase reduced it (Figure 4b ). These results are in good agreement with the effect on cell death and further confirm that PI 3-kinase accelerates the formation of autophagosome during glucose deprivation.
In this report, we use inhibitors and adenovirusmediated gene transfers to show that class I PI 3-kinase accelerates autophagic cell death by accelerating the accumulation of autophagic vacuoles, as revealed by dye-exclusion assay, MDC staining, light and electron microscopy, and Western blotting analysis of LC3. Our present result that class I PI 3-kinase accelerates autophagic cell death is apparently inconsistent to the previous report that class I PI 3-kinase inhibits autophagic protein degradation (Petiot et al., 2000; Arico et al., 2001) . Thus, class I PI 3-kinases might accelerate the accumulation of autophagic vacuoles and subsequent cell death by inhibiting autophagic protein degradation. Autophagic cell death might occur in cells in which the balance between autophagosome formation and lysosomal protein degradation is disrupted, and, as a result, autophagic vacuoles accumulate in the cytoplasm. In accordance with the idea, it has been reported that either mutation in -or knock out of -the lysosome-associated membrane protein-2 (LAMP-2) gene causes lysosomal dysfunction and subsequent cardiomyopathy with autophagic vacuoles, in which autophagic protein degradations are severely impaired (Nishino et al., 2000; Tanaka et al., 2000) .
Chi et al. reported that the overexpression of oncogenic ras in human cancer cells results in caspaseindependent cell death with autophagic vacuoles (Chi et al., 1999) . They also reported caspase-independent neuroblastoma cell death with the increase of ras oncogene expression and the generation of autophagic vacuoles during regression of neuroblastoma (Kitanaka et al., 2002) . Since class I PI 3-kinase is known to be a downstream effector of ras (Rodriguez-Viciana et al., 1994) , the IGF-I/ras/PI 3-kinase pathway might accelerate autophagic cell death. Moreover, it has been recently reported that overexpression of death-associated protein kinase (DAPk) causes autophagic cell death in various cells (Inbal et al., 2002) . Further studies Figure 3 Continued PI 3-kinase accelerates autophagic cell death T Aki et al are necessary to clarify the relationships among these molecules in the acceleration of autophagic cell death. In conclusion, this is the first report to our knowledge that demonstrates an accelerating role of IGF-I/PI 3-kinase in programmed cell death.
Abbreviations PI, phosphoinositide; 3MA, 3-methyladenine; Z-VAD-FMK, benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone; IGF, insulin-like growth factor; LC3, microtubule-associated protein 1 light chain 3. Figure 4 Effect of inhibitors (a) or the overexpression of wild-type or dominant-negative PI 3-kinases (b) on the formation of LC3-II during glucose deprivation. Western blot analyses were performed as described (Aki et al., 2001) . Equal amounts of cell extract were subjected to electrophoresis in 15% gels, blotted onto nitrocellulose membranes, and probed with anti-LC3 antibody (Kabeya et al., 2000) 
